LMWH Dosing for DVT Prophylaxis

Standard Prophylactic Dosing Regimens

The American College of Cardiology recommends enoxaparin 40 mg subcutaneously once daily or dalteparin 5000 units subcutaneously once daily for DVT prophylaxis in general surgical and medical patients 1, 2
Enoxaparin 40 mg subcutaneously once daily is the standard prophylactic dose for most patients, as recommended by the Mayo Clinic 3, 1
Dalteparin 5000 units subcutaneously once daily is an equivalent alternative, according to the Mayo Clinic Proceedings 3
Once-daily dosing is preferred over twice-daily administration for prophylaxis, improving patient compliance and reducing nursing burden, as stated by the Praxis Medical Insights 1

LMWH offers a lower risk of heparin-induced thrombocytopenia (HIT) compared to unfractionated heparin, as reported in Blood 4, 1
No requirement for routine laboratory monitoring in most patients, reducing healthcare costs, according to Blood and Praxis Medical Insights 4, 1
LMWH facilitates outpatient prophylaxis due to simple once-daily subcutaneous administration, as recommended by Praxis Medical Insights 1

In severe renal insufficiency (CrCl <30 mL/min), consider unfractionated heparin 5000 units subcutaneously twice daily instead of LMWH, due to LMWH accumulation risk, as stated in Blood and Praxis Medical Insights 4, 1
If LMWH must be used in renal impairment, reduce enoxaparin to 30 mg subcutaneously once daily for prophylaxis, according to Praxis Medical Insights 1, 2
Measure creatinine clearance before initiating therapy to identify patients requiring dose adjustment, as recommended by Praxis Medical Insights 2
LMWH is strongly preferred over unfractionated heparin in cancer patients due to demonstrated mortality benefit, as reported in Blood 4
Standard prophylactic doses apply in cancer patients unless treating active thrombosis, according to Blood and Mayo Clinic Proceedings 4, 3
LMWH is the anticoagulant of choice over warfarin for both prophylaxis and treatment in pregnancy, as stated in Mayo Clinic Proceedings 3
Enoxaparin 40 mg once daily or dalteparin 5000 units once daily is recommended for antepartum prophylaxis in high-risk pregnant patients, according to Mayo Clinic Proceedings 3

Do not use standard prophylactic doses in patients with severe renal impairment (CrCl <30 mL/min) without dose reduction or switching to unfractionated heparin, as warned by Praxis Medical Insights 1, 2
Do not assume all LMWHs are interchangeable—they differ in molecular weight, half-life, and FDA-approved indications, according to Praxis Medical Insights 2
Do not administer LMWH intravenously—subcutaneous administration is the only appropriate route for prophylaxis, as stated by Praxis Medical Insights 1
Monitor platelet counts in high-risk patients (prior HIT, prolonged therapy >7 days), though routine monitoring is not required, as recommended by Praxis Medical Insights 1

Continue prophylaxis throughout hospitalization for medical patients and surgical patients with ongoing risk factors, as recommended by Blood and Mayo Clinic Proceedings 4, 3
Extended prophylaxis beyond hospital discharge may be warranted in high-risk surgical patients (major cancer surgery, orthopedic procedures), according to Mayo Clinic Proceedings 3